Accounting reportsPreviously
|
Name | APTEKA N165, OOO |
---|
INN | 4217181247 |
---|
KPP | 421701001 |
---|
OGRN | 1164205085846 |
---|
OKPO | 16351954 |
---|
Address | 654041, Kemerovskaya Oblast' - Kuzbass, g. Novokuznetsk, pr-kt Oktyabr'skiy (tsentral'nyy R-n), d. D. 12 |
|
OKVED code | Type | Name of activity type |
---|
47.73 | Core activity | Retailing drugs in specialized stores (pharmacies) | 47.19.2 | Additional activity | Retail sale of goods of various kinds, the main direction of non-food | 47.74 | Additional activity | Retailing products used for medical purposes, orthopedic goods in specialized stores | All types of activities | 47.75 | Additional activity | Retailing of cosmetics and personal hygiene products in specialized stores | 47.91 | Additional activity | Mail order and Internet retailers | 47.99 | Additional activity | Other retail sale not in stores, stalls or markets | 68.10.2 | Additional activity | Buying and selling of own real estate and commercial non-residential buildings | 68.20.2 | Additional activity | Renting and operating of own or leased commercial properties and non- residential buildings | 68.32.2 | Additional activity | Management of commercial real estate and non-residential buildings for third parties | 73.11 | Additional activity | Activities of advertising agencies | 73.20 | Additional activity | Market research and public opinion polling |
Registration date | 22.12.2016 |
---|
|
APTEKA N165, OOO (Kemerovo Oblast; INN 4217181247) was registered on 22 Dec 2016. The company's authorized capital as of July 1, 2012 was 6779000 rub. Principal activities of APTEKA N165, OOO: retailing drugs in specialized stores (pharmacies) (47.73), retail sale of goods of various kinds, the main direction of non-food (47.19.2), retailing products used for medical purposes, orthopedic goods in specialized stores (47.74). |
Economic indicators2023
Net profit (RAS) of APTEKA N165, OOO dropped in 2023 2.42 times to 7.03 million RUB from 17.02 million RUB over the same period in 2022, the company informed. Revenue increased in the accounting period by 13.97% to 413.67 million RUB from 362.98 million RUB over 2022. 2022
Net profit (RAS) of APTEKA N165, OOO dropped in 2022 by 7.96% to 17.02 million RUB from 18.49 million RUB over the same period in 2021, the company informed. Revenue decreased in the accounting period by 1.38% to 362.98 million RUB from 368.05 million RUB in 2021. 2021
Net profit (RAS) of APTEKA N165, OOO grew over 2021 15.00 times to 18.49 million RUB from 1.23 million RUB over 2020, the company informed. Revenue remained in the accounting period at the same level and made up 368.05 million RUB compared to 366.78 million RUB 366.78 million RUB. 2020
Net profit (RAS) of APTEKA N165, OOO dropped in 2020 by 49.57% to 1.23 million RUB from 2.45 million RUB over the same period in 2019, the company informed. Revenue increased in the accounting period by 10.90% to 366.78 million RUB from 330.72 million RUB over 2019. 2019
Net profit (RAS) of APTEKA N165, OOO grew over 2019 7.64 times to 2.45 million RUB from 320.00 thousand RUB over 2018, the company informed. Revenue decreased in the accounting period by 11.08% to 330.72 million RUB from 371.91 million RUB in 2018; cost of goods sold decreased by 12.24% to 288.73 million RUB from 329.00 million RUB; sales loss made up 5.18 million RUB compared to sales profit of 532.00 thousand RUB. 2018
Net profit (RAS) of APTEKA N165, OOO grew over 2018 2.16 times to 320.00 thousand RUB from 148.00 thousand RUB over 2017, the company informed. Revenue increased in the accounting period by 12.73% to 371.91 million RUB from 329.91 million RUB over 2017; cost of goods sold grew by 11.23% to 329.00 million RUB from 295.79 million RUB; sales profit made up 532.00 thousand RUB compared to sales loss of 4.10 million RUB. 2017
Net profit (RAS) of APTEKA N165, OOO made up 148.00 thousand RUB over 2017 compared to net loss of 29.50 million RUB over 2016, the company informed. Revenue increased in the accounting period 1.93 times to 329.91 million RUB from 170.71 million RUB over 2016; cost of goods sold grew 1.97 times to 295.79 million RUB from 150.47 million RUB; sales loss decreased 2.64 times to 4.10 million RUB from 10.82 million RUB. 2016
Net loss (RAS) of APTEKA N165, OOO increased 3.00 times to 29.50 million RUB from 9.85 million RUB over 2015, the company informed. Revenue increased in the accounting period 2.76 times to 170.71 million RUB from 61.91 million RUB over 2015; cost of goods sold grew 2.93 times to 150.47 million RUB from 51.34 million RUB; sales loss grew 1.84 times to 10.82 million RUB from 5.89 million RUB.
unlimited access to database "Kontragent" download any information within 24 hours
Companies in the region
|